Preleukemia: the normal side of cancer

LI Shlush, MD Minden - Current opinion in hematology, 2015 - journals.lww.com
LI Shlush, MD Minden
Current opinion in hematology, 2015journals.lww.com
The latent preleukemic period before overt leukemia presents can take years, and the
majority of carriers will never develop leukemia in their lifetime. The preleukemic state is not
rare, with greater than 1% of individuals having acquired one or more of the recognized
preleukemic lesions. The high frequency of such abnormalities in the population may be the
cost of growing old; however, another view could be that in order to survive to old age, the
hematopoietic system must adapt to create robust hematopoietic stem/progenitor cells with …
Summary
The latent preleukemic period before overt leukemia presents can take years, and the majority of carriers will never develop leukemia in their lifetime. The preleukemic state is not rare, with greater than 1% of individuals having acquired one or more of the recognized preleukemic lesions. The high frequency of such abnormalities in the population may be the cost of growing old; however, another view could be that in order to survive to old age, the hematopoietic system must adapt to create robust hematopoietic stem/progenitor cells with an increased fitness and clonal expansion. Hence, leukemia does not necessarily start as a disease, but rather as a need, with the normally functioning preleukemic hematopoietic stem cells trying to maintain health for years but in time succumbing to their own acquired virtues.
Lippincott Williams & Wilkins